Intermittent theta-burst stimulation for autism spectrum disorder

Intermittent theta-burst trans-cranial magnetic stimulation for autism spectrum disorder: A randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220204053933N1

Enrollment

Registered

2022-03-13

Start date

2022-03-05

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder. Autistic disorder

Interventions

Intervention 1: Intervention group: 15 theta burst stimulation sessions (one session per day for 3 consecutive weeks) will be conducted for each participant in the intervention group. In this study, e

Eligibility

Sex/Gender

All

Age

9 Years to 17 Years

Inclusion criteria

Inclusion criteria: Patients with autism spectrum disorder (ASD) aged 9 to 17 years Mild to moderate ASD Stable clinical conditions in the last 2 months Stable treatment schedule in the last 2 months Intelligence quotient of 55 or greater on the Wechsler test

Exclusion criteria

Exclusion criteria: Patients with severe ASD Intelligence quotient <55 based on Wechsler intelligence test History of seizures History of serious head trauma The presence of implants in the brain History of substance abuse

Design outcomes

Primary

Measure	Time frame
Severity of Autism Spectrum Disorder Symptoms Based on Autism Behavior Checklist. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Autism Behavior Checklist.;Severity of obsessive-compulsive symptoms based on score of Yale-Brown Obsessive Compulsive Scale (YBOCS). Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Yale-Brown Obsessive Compulsive Scale (YBOCS).;Changes in selective attention based on Stroop test. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Stroop test.;Change in executive function based on Wisconsin Card Sorting Test. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Wisconsin Card Sorting Test.	—

Measure

Time frame

Severity of Autism Spectrum Disorder Symptoms Based on Autism Behavior Checklist. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Autism Behavior Checklist.;Severity of obsessive-compulsive symptoms based on score of Yale-Brown Obsessive Compulsive Scale (YBOCS). Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Yale-Brown Obsessive Compulsive Scale (YBOCS).;Changes in selective attention based on Stroop test. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Stroop test.;Change in executive function based on Wisconsin Card Sorting Test. Timepoint: Evaluation before the intervention, immediately after the end of 15 sessions, one month after the end of the sessions. Method of measurement: Wisconsin Card Sorting Test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Javad Alaghband Rad

Tehran University of Medical Sciences

dralaghbandrad@gmail.com+98 21 5541 2244

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026